Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis
about
Adverse Effects of GLP-1 Receptor AgonistsThe Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in KoreaDetection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic reviewTLQP-21 protects human umbilical vein endothelial cells against high-glucose-induced apoptosis by increasing G6PD expressionGlucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malariaAdverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer.Adverse Effects Associated With Newer Diabetes Therapies.Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.GLP-1 based therapies: clinical implications for gastroenterologists.Cardiovascular safety and benefits of GLP-1 receptor agonists.ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial.
P2860
Q26801346-63DE7053-3E7E-4CB4-9E89-80F3FA744C48Q26852590-0B6E5A68-AD48-41E9-B07C-D8311BB3BAEAQ27007060-33BD36BC-41CC-4887-BBC3-7428BFA0DEB9Q28076726-76BCE9B4-2524-4EDE-983B-B3821D6B581CQ28535350-9CF09416-2B5F-4158-8533-3362654132A5Q28597322-1A75F270-022B-421B-877E-90D517DA8E83Q38264360-EA7BBF8E-B710-4999-882B-D53662EBEAACQ38546214-FE51EE6F-EF8B-4E55-9002-4998084DE0E2Q38616170-C0F358B4-EABB-4CA8-8071-6449FAA66471Q38703292-14739C60-869F-43E1-BB7F-A5C7FCB49DB0Q39013056-AC472F5F-A5DB-4E47-A890-759547D39173Q46375223-D4F3B9DD-CABB-4421-B42E-0D437BF7B74AQ47221869-F3721E15-C030-4DE0-AFB0-0D34CCA160AF
P2860
Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@ast
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@en
type
label
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@ast
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@en
prefLabel
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@ast
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@en
P2093
P2860
P921
P356
P1476
Impact of GLP-1 receptor agoni ...... tment comparison meta-analysis
@en
P2093
Shanshan Wu
Siyan Zhan
Yuan Zhang
Zhirong Yang
P2860
P304
P356
10.1155/2012/230624
P5008
P577
2012-12-26T00:00:00Z